Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus-coated tympanostomy tube on rat tympanic membrane.
Akbulut S, Altintaş H, Berk D, Sezen OS, Barisik NO. Akbulut S, et al. Among authors: berk d. Int J Pediatr Otorhinolaryngol. 2013 Jul;77(7):1147-51. doi: 10.1016/j.ijporl.2013.04.027. Epub 2013 May 22. Int J Pediatr Otorhinolaryngol. 2013. PMID: 23707155
Myopericytoma of the tongue: a case report.
Akbulut S, Berk D, Demir MG, Kayahan S. Akbulut S, et al. Among authors: berk d. Acta Medica (Hradec Kralove). 2013;56(3):124-5. doi: 10.14712/18059694.2014.20. Acta Medica (Hradec Kralove). 2013. PMID: 24592750 Free article.
Vocal fold paresis accompanying vocal fold polyps.
Akbulut S, Inan RA, Altintas H, Gul I, Berk D, Paksoy M. Akbulut S, et al. Among authors: berk d. Eur Arch Otorhinolaryngol. 2015 Jan;272(1):149-57. doi: 10.1007/s00405-014-3227-8. Epub 2014 Aug 20. Eur Arch Otorhinolaryngol. 2015. PMID: 25138152
Correction to: Cytotoxicity of Prymnesium parvum extracts and prymnesin analogs on epithelial fish gill cells RTgill-W1 and the human colon cell line HCEC-1CT.
Varga E, Prause HC, Riepl M, Hochmayr N, Berk D, Attakpah E, Kiss E, Medić N, Del Favero G, Larsen TO, Hansen PJ, Marko D. Varga E, et al. Among authors: berk d. Arch Toxicol. 2024 Apr 9. doi: 10.1007/s00204-024-03716-3. Online ahead of print. Arch Toxicol. 2024. PMID: 38592475 No abstract available.
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: a 52-week, phase 2, open-label trial.
Stein Gold L, Adam DN, Albrecht L, Alonso-Llamazares J, Ferris LK, Gooderham MJ, Hong HC, Kempers SE, Kircik LH, Lebwohl M, Loo WJ, Nahm WK, Papp KA, Stewart D, Toth DP, Zirwas M, Krupa D, Snyder S, Burnett P, Higham R, Berk DR. Stein Gold L, et al. Among authors: berk dr. J Am Acad Dermatol. 2024 Mar 29:S0190-9622(24)00541-3. doi: 10.1016/j.jaad.2024.03.030. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38556093 Free article.
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.
Blauvelt A, Draelos ZD, Stein Gold L, Alonso-Llamazares J, Bhatia N, DuBois J, Forman SB, Gooderham M, Green L, Guenthner ST, Hebert AA, Lain E, Moore AY, Papp KA, Zirwas M, Kato S, Snyder S, Krupa D, Burnett P, Berk DR, Chu DH. Blauvelt A, et al. Among authors: berk dr. J Am Acad Dermatol. 2024 May;90(5):986-993. doi: 10.1016/j.jaad.2023.12.065. Epub 2024 Jan 20. J Am Acad Dermatol. 2024. PMID: 38253129 Free article. Clinical Trial.
195 results